The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked?

References

• Barratt, M.J., Ferris, J.A., Zahnow, R., Palamar, J.J., Maier, L.J., & Winstock, A.R. (2017). Moving on from representativeness: Testing the utility of the global drug survey. Substance Abuse, 11, 1–17. doi:10.1177/1178221817716391
   PubMed Web of Science ®Google Scholar
• Bates, G., Begley, E., Tod, D., Jones, L., Leavey, C., & McVeigh, J. (2017). A systematic review investigating the behaviour change strategies in interventions to prevent misuse of anabolic steroids. Journal of Health Psychology, 1–18. doi:10.1177/1359105317737607
   PubMed Web of Science ®Google Scholar
• Begley, E., McVeigh, J., Hope, V., Bates, G., Glass, R., Campbell, J., … Smith, J. (2017). Image and performance enhancing drugs: 2016 National survey results. Liverpool, UK: Public Health Institute, LJMU.
   Google Scholar
• Boardley, I.D., & Grix, J. (2014). Doping in bodybuilders: A qualitative investigation of facilitative psychosocial processes. Qualitative Research in Sport, Exercise and Health, 6, 422–439. doi:10.1080/2159676X.2013.766809
   Google Scholar
• Christiansen, A.V., Vinther, A.S., & Liokaftos, D. (2017). Outline of a typology of men’s use of anabolic androgenic steroids in fitness and strength training environments. Drugs: Education, Prevention and Policy, 24, 295–305. doi:10.1080/09687637.2016.1231173
   Web of Science ®Google Scholar
• Dunn, M., Henshaw, R., & McKay, F.H. (2016). Do performance and image enhancing drug users in regional Queensland experience difficulty accessing health services? Drug and Alcohol Review, 35, 377–382. doi:10.1111/dar.12363
   Web of Science ®Google Scholar
• Dunn, M., McKay, F.H., & Iversen, J. (2014). Steroid users and the unique challenge they pose to needle and syringe program (NSP) workers. Drug and Alcohol Review, 33, 71–77. doi:10.1111/dar.12085
   PubMed Web of Science ®Google Scholar
• Evans Brown, M., McVeigh, J., Perkins, C., & Bellis, M.A. (2012). Human enhancement drugs. The emerging challenges to public health. Liverpool: North West Public Health Observatory.
   Google Scholar
• Griffiths, S., Henshaw, R., McKay, F.H., & Dunn, M. (2017). Post-cycle therapy for performance and image enhancing drug users: A qualitative investigation. Performance Enhancement & Health, 5, 103–107. doi:10.1016/j.peh.2016.11.002
   Google Scholar
• Hoberman, J. (2005). Dopers in Uniform: Cops on Steroids. Retrieved from https://thinksteroids.com/articles/dopers-uniform-cops-steroids/
   Google Scholar
• Hoberman, J. (2017). Dopers in uniform: The hidden world of police on steroids. USA: University of Texas Press.
   Google Scholar
• Home Office. (2017). Crime survey for England and Wales: Year ending September 2017. UK: Office for National Statistics.
   Google Scholar
• Hope, V.D., McVeigh, J., Marongiu, A., Evans-Brown, M., Smith, J., Kimergård, A., … Ncube, F. (2013). Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: A cross-sectional study. BMJ Open, 3, 1–11. doi:10.1136/bmjopen-2013-003207
   Web of Science ®Google Scholar
• Iversen, J., Hope, V.D., & McVeigh, J. (2016). Access to needle and syringe programs by people who inject image and performance enhancing drugs. International Journal of Drug Policy, 31, 199–200. doi:10.1016/j.drugpo.2016.01.016
   PubMed Web of Science ®Google Scholar
• Kimergård, A. (2015). A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: Motives, beliefs and experiences. Journal of Substance Use, 20, 288–294. doi:10.3109/14659891.2014.911977
   Web of Science ®Google Scholar
• Kimergård, A., & McVeigh, J. (2014). Variability and dilemmas in harm reduction for anabolic steroid users in the UK: A multi-area interview study. Harm Reduction Journal, 11, 19. doi:10.1186/1477-7517-11-19
   PubMed Web of Science ®Google Scholar
• Larance, B., Degenhardt, L., Copeland, J., & Dillon, P. (2008). Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs. Drug Alcohol Rev, 27, 679–686. doi:10.1080/09595230802392568
   PubMed Web of Science ®Google Scholar
• McVeigh, J., Beynon, C., & Bellis, M.A. (2003). New challenges for agency based syringe exchange schemes: Analysis of 11 years of data (1991–2001) in Merseyside and Cheshire, United Kingdom. International Journal of Drug Policy, 14, 399–405. doi:10.1016/s0955-3959(03)00141-5
   Google Scholar
• McVeigh, J., Evans-Brown, M., & Bellis, M.A. (2012). Human enhancement drugs and the pursuit of perfection. Adicciones, 24, 185–190. doi:10.20882/adicciones.88
   PubMed Web of Science ®Google Scholar
• Modesto-Lowe, V., Petry, N.M., & McCartney, M. (2008). Intervening early to reduce developmentally harmful substance use among youth populations. The Medical Journal of Australia, 188, 494–495.
   PubMed Web of Science ®Google Scholar
• Niedfeldt, M.W. (2018). Anabolic steroid effect on the liver. Current Sports Medicine Reports, 17, 97–102. doi:10.1249/jsr.0000000000000467
   PubMed Web of Science ®Google Scholar
• Pope, H.G., Kanayama, G., Ionescu-Pioggia, M., & Hudson, J.I. (2004). Anabolic steroid users’ attitudes towards physicians. Addiction, 99, 1189–1194. doi:10.1111/j.1360-0443.2004.00781.x
   PubMed Web of Science ®Google Scholar
• Pope, H.G., Wood, R.I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014). Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement. Endocrine Reviews, 35, 341–375. doi:10.1210/er.2013-1058
   PubMed Web of Science ®Google Scholar
• Sagoe, D., Andreassen, C.S., & Pallesen, S. (2014). The aetiology and trajectory of anabolic-androgenic steroid use initiation: A systematic review and synthesis of qualitative research. Substance Abuse Treatment, Prevention, and Policy, 9, 27. doi:10.1186/1747-597x-9-27
   PubMed Web of Science ®Google Scholar
• Sagoe, D., McVeigh, J., Bjornebekk, A., Essilfie, M.S., Andreassen, C.S., & Pallesen, S. (2015). Polypharmacy among anabolic-androgenic steroid users: A descriptive metasynthesis. Substance Abuse Treatment, Prevention, and Policy, 10, 12. doi:10.1186/s13011-015-0006-5
   PubMed Web of Science ®Google Scholar
• Sagoe, D., Molde, H., Andreassen, C.S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: A meta-analysis and meta-regression analysis. Annals of Epidemiology, 24, 383–398. doi:10.1016/j.annepidem.2014.01.009
   PubMed Web of Science ®Google Scholar
• Stockings, E., Hall, W.D., Lynskey, M., Morley, K.I., Reavley, N., Strang, J., … Degenhardt, L. (2016). Prevention, early intervention, harm reduction, and treatment of substance use in young people. The Lancet Psychiatry, 3, 280–296. doi:10.1016/S2215-0366(16)00002-X
   PubMed Web of Science ®Google Scholar
• Tighe, B., Dunn, M., McKay, F.H., & Piatkowski, T. (2017). Information sought, information shared: Exploring performance and image enhancing drug user-facilitated harm reduction information in online forums. Harm Reduction Journal, 14, 48. doi:10.1186/s12954-017-0176-8
   PubMed Web of Science ®Google Scholar
• Underwood, M. (2017). Exploring the social lives of image and performance enhancing drugs: An online ethnography of the Zyzz fandom of recreational bodybuilders. International Journal of Drug Policy, 39, 78–85. doi:10.1016/j.drugpo.2016.08.012
   PubMed Web of Science ®Google Scholar
• van de Ven, K., Maher, L., Wand, H., Memedovic, S., Jackson, E., & Iversen, J. (2018). Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia. Drug and Alcohol Review, 37, 837–846. doi:10.1111/dar.12831
   PubMed Web of Science ®Google Scholar
• van de Ven, K., & Mulrooney, K.J.D. (2017). Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium. International Journal of Drug Policy, 40, 6–15. doi:10.1016/j.drugpo.2016.07.009
   PubMed Web of Science ®Google Scholar
• Zahnow, R., McVeigh, J., Bates, G., Hope, V., Kean, J., Smith, J., & Campbell, J. (2018). Identifying a typology of men who use anabolic androgenic steroids (AAS). International Journal of Drug Policy, 8, 105–112.
   Google Scholar
• Zahnow, R., McVeigh, J., Ferris, J., & Winstock, A. (2017). Adverse effects, health service engagement, and service satisfaction among anabolic androgenic steroid users. Contemporary Drug Problems, 44, 69–83. doi:10.1177/0091450917694268
   Google Scholar